MPT Product Development Database

This database includes MPT products that are currently available, as well as MPT products in active development. In addition, a number of existing products and products in development for single indications are also included. The database outlines detailed product information and can be searched to display products by desired criteria as selected from the drop-down boxes or by entering a keyword in the search box. Click on the product name to access detailed information on each product. Click here to learn more about the inclusion criteria and information update methodology.

Links to Summary Tables outlining (1) MPT Products in Development, (2) Existing Single Indication Products or (3) Candidate Single Indication Products that could serve as potential components of future MPTs can be found below.
Help us keep the database complete and up to date!
If you know of an MPT product not included in the database or have updated information for listed products, please contact us using the “MPT Database Feedback” form.
Check out the MPT products in the development pipeline – view an MPT Pipeline Table by Indication Combination.
Product TypeDelivery RouteDelivery MethodDevelopment Stage
       
IndicationProduct DeveloperProduct Sponsor/FundingActive Ingredient
       
Key Word Search   
       

69 product(s) found

Results: 1 product(s) found
Product Name
Product Type
Delivery Route
Delivery Method
Active Ingredient
Developer
Stage
Indication(s)
Truvada Existing Single Indication-HIV Prevention Systemic Pill/Capsule/Tablet- Oral
  • Emtricitabine (FTC)
  • Tenofovir Disoproxil Fumarate (TDF)
  • Gilead Sciences, Inc.
  • A
  • HIV
  • IMPT Secretariat
    308 Natoma Street
    Suite 150
    Folsom, CA 95630
    916-932-4785 | This email address is being protected from spambots. You need JavaScript enabled to view it.

    © Copyright 2016, The IMPT. All rights reserved.

    The Initiative for Multipurpose Prevention Technologies (IMPT) is a project of CAMI Health, an organization dedicated women’s reproductive health and empowerment. CAMI Health is housed at the Public Health Institute (PHI).